Complement inhibition by C3-siRNA treatment prevents AChR loss and reduces complement activation in the rat Passive Transfer Myasthenia Gravis (PTMG)
Anja Kristina Schöttler, Marina Mané-Damas, Britt Arets, Marc H. De Baets, Sandra M.H. Claessen, Tara Barbour, Erik Richardson, David J. Eyerman, Lukas Scheibler, Mario H. Losen, Pilar Martínez‐Martínez
C3-siRNA treatment in PTMG rats reduces AChR loss and MAC deposition, improving muscle function and suggesting complement inhibition as a therapeutic strategy for AChR-MG.
bioRxiv · Aug 31, 2025 · PreprintImmunology